Research Topics
Species | S Eva SingletarySummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging ManualS Eva Singletary
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4095, USA
Cancer 98:2740-1. 2003
Locoregional treatment outcomes after multimodality management of inflammatory breast cancerIan J Bristol
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 72:474-84. 2008....
Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data BaseS Eva Singletary
University of Texas M D Anderson Cancer Center, Houston, TX 77030 4095, USA
Ann Surg 242:281-9. 2005..To examine treatment trends in invasive lobular carcinoma (ILC) over the last 15 years and, in particular, to compare rates of recurrence and disease-free survival associated with breast conservation therapy compared with mastectomy...
Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapyThomas A Buchholz
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer 104:676-81. 2005..To the authors' knowledge there are few data that correlate the expression of the epidermal growth factor receptor (EGFR) with the outcome of patients who have breast carcinoma and are treated with anthracycline chemotherapy...
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrenceJeannie Shen
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Cancer 104:479-90. 2005..Determinants of prognosis after IBTR should be taken into account when evaluating the need for further systemic therapy and designing risk-stratified clinical trials...
Paget's disease of the breast: there is a role for breast-conserving therapyKazumi Kawase
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, Texas 77030, USA
Ann Surg Oncol 12:391-7. 2005..CONCLUSIONS: Paget's disease of the breast is almost always associated with an underlying breast cancer. Breast-conserving approaches result in local control and survival rates similar to those achieved with mastectomy...
Improving local control with breast-conserving therapy: a 27-year single-institution experienceNeslihan Cabioglu
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 104:20-9. 2005..The current low incidence of IBTR with multidisciplinary management of breast carcinoma may result in more patients choosing BCT over mastectomy...
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situTina W F Yen
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Am Coll Surg 200:516-26. 2005..Risks and benefits of SLNB should be discussed with patients who are younger, are diagnosed by core-needle biopsy, or have large or high-grade DCIS...
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistryAnees Chagpar
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 103:1581-6. 2005..543 and P = 0.540, respectively). CONCLUSIONS: Although the finding of SLN micrometastases by IHC may change management in > 12% of patients, preliminary results suggested that such micrometastases do not affect outcomes significantly...
Breast conservation after neoadjuvant chemotherapyAllen M Chen
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 103:689-95. 2005..The MDAPI enabled the identification of a small group (4%) of patients who are at high risk for IBTR and LRR and who may benefit from alternative locoregional treatment strategies...
Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary studySavitri Krishnamurthy
Department of Cytopathology, Unit 53, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Cancer 102:322-7. 2004....
Introduction of Dr. Alfred M. CohenS Eva Singletary
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, TX 77030-4095, USA
Ann Surg Oncol 11:795-7. 2004
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinomaJeannie Shen
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
Cancer 101:1330-7. 2004..Identification of malignant intraMLNs by lymphatic mapping may help to identify high-risk patients for whom further evaluation of the axillary lymph nodes is warranted despite otherwise clinically negative findings in the axilla...
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapyJeannie Shen
Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Ann Surg Oncol 11:854-60. 2004..These patients have favorable rates of long-term local control and survival. Mastectomy is not mandatory for all patients with breast cancer who present with skin involvement...
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancerThomas A Buchholz
Department of Radiation Oncology, Breast Medical Oncology, Surgical Oncology, and Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 11:8398-402. 2005....
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapyLinda J Adepoju
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 106:42-50. 2006..Concurrent ADH, ALH, or LCIS with DCIS is not a contraindication to BCT...
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapyAnees B Chagpar
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4095, USA
Ann Surg 243:257-64. 2006..CONCLUSION: Physical examination, ultrasonography, and mammography were only moderately useful for predicting residual pathologic tumor size after neoadjuvant chemotherapy...
Timing of surgical intervention for the intact primary in stage IV breast cancer patientsRoshni Rao
Division of Surgical Oncology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9155, USA
Ann Surg Oncol 15:1696-702. 2008..The subset of patients who would most benefit from surgery remains unclear. This study evaluates the pathological attributes and optimum timing for surgery in patients who present with stage IV breast cancer and an intact primary...
Surgical management of inflammatory breast cancerS Eva Singletary
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Semin Oncol 35:72-7. 2008..However, there are no medical contraindications to breast reconstruction after mastectomy, although most clinicians prefer to wait until after the completion of radiotherapy before attempting this additional surgery...
Defining the clinical diagnosis of inflammatory breast cancerS Eva Singletary
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Semin Oncol 35:7-10. 2008..Accurate diagnosis is critically important, as multimodal therapy can significantly improve outcomes if instituted early enough...
Overview of adjuvant systemic therapy in early stage breast cancerLisa A Newman
Breast Care Center, 1500 East Medical Center Drive, 3308 CGC, University of Michigan, Ann Arbor, MI 48109, USA
Surg Clin North Am 87:499-509, xi. 2007..Ongoing clinical and translational research in breast cancer seeks to improve the efficacy of systemic agents for use in the conventional postoperative (adjuvant) setting...
Multidisciplinary frontiers in breast cancer management: a surgeon's perspectiveS Eva Singletary
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
Cancer 109:1019-29. 2007..It will be important for surgeons to stay aware of all developments that may improve the care of their patients and to be true surgical oncologists rather than merely surgical technicians...
Role for intraoperative margin assessment in patients undergoing breast-conserving surgeryNeslihan Cabioglu
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, 77030, USA
Ann Surg Oncol 14:1458-71. 2007..We investigated whether intraoperative margin assessment aids in obtaining negative margins, and to evaluate the local control thus achieved...
Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapyFlorentia Peintinger
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Ann Surg Oncol 13:1443-9. 2006..Agreement of residual tumor size in mammography and sonography with pathologic residual tumor size was moderate...
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapyFlorentia Peintinger
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 107:1248-54. 2006..Prospective studies are needed to examine whether decreasing the RVs in this patient population leads to an increased LRR rate...
Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancerKazumi Kawase
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Am Coll Surg 203:64-72. 2006..Longterm followup of patients with lymphoscintigraphic evidence of extraaxillary drainage is needed to determine whether regional and systemic recurrence patterns differ in these patients...
Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancerThomas A Buchholz
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 65:1155-60. 2006....
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective studyJeanne A Petrek
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J Clin Oncol 24:1045-51. 2006..CONCLUSION: Using daily menstrual bleeding records, it is demonstrated that age, the specific chemotherapy regimen received, and tamoxifen use impact ovarian function...
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsyLaura A Lambert
Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Ann Surg Oncol 13:310-20. 2006..TIC seems to be an acceptable substitute for frozen section as a nomogram variable. The nomogram may help predict an individual's risk of non-SLN metastases and assist in patient decision making regarding the benefit of CLND...
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapyBryan T Hennessy
Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 106:1000-6. 2006..The purpose of the current study was to determine long-term outcome in patients achieving a pCR of cytologically proven inflammatory breast carcinoma ALN metastases after primary chemotherapy...
Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple dischargeNeslihan Cabioglu
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 101:508-17. 2004..Nonetheless, BCS can be performed safely if negative margins are achieved and if appropriate adjuvant radiotherapy or systemic therapy is administered...
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experienceAllen M Chen
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 22:2303-12. 2004..Advanced nodal involvement at diagnosis, residual tumor larger than 2 cm, multifocal residual disease, and lymphovascular space invasion predict higher rates of LRR and IBTR...
Minimally invasive operation for breast cancerS Eva Singletary
University of Texas M.D. Anderson Cancer Center, Houston, USA
Curr Probl Surg 41:394-447. 2004
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapyFunda Meric
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 97:926-33. 2003....
Breast cancer recurrence after immediate reconstruction: patterns and significanceHoward N Langstein
Department of Plastic Surgery, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Plast Reconstr Surg 111:712-20; discussion 721-2. 2003..These data support the continued use of immediate breast reconstruction without fear of concealing a recurrence or influencing the oncologic outcome...
Surgical margins in patients with early-stage breast cancer treated with breast conservation therapyS Eva Singletary
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 444, Houston TX 77030 4095, USA
Am J Surg 184:383-93. 2002..This review examines published reports about standard and innovative approaches to assessing surgical margins, the clinical significance of margin size, and risk factors for positive margins...
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrencesEugene Huang
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 95:2059-67. 2002..This is because patients with new carcinomas had significantly lower rates of metastasis than those with local disease recurrence, but were more likely to develop contralateral breast carcinomas...
Treatment and outcome of patients with intracystic papillary carcinoma of the breastCarmen C Solorzano
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Surg 184:364-8. 2002..Intracystic papillary carcinoma (IPC) of the breast is a rare form of noninvasive breast cancer. An appreciation of associated pathology with IPC may be critical in surgical decision-making...
Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancerEugene Huang
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 53:1225-33. 2002..Alternative therapeutic strategies such as novel systemic agents, use of planned myocutaneous repair for closure, or radiation combined with radiosensitizing agents, should be considered in this class of patients...
Long-term complications associated with breast-conservation surgery and radiotherapyFunda Meric
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
Ann Surg Oncol 9:543-9. 2002..Breast-conservation surgery and radiotherapy is associated with grade 2 or greater complications in only 9.9% of patients. Nearly half of these complications are attributable to axillary dissection...
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapyThomas A Buchholz
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 53:880-8. 2002..To compare the pathologic factors associated with postmastectomy locoregional recurrence (LRR) in breast cancer patients not receiving radiation who were treated with neoadjuvant chemotherapy (NEO) vs. adjuvant chemotherapy (ADJ)...
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapyNadeem Q Mirza
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Ann Surg Oncol 9:256-65. 2002..Disease-specific survival among patients with LRR was similar to that among patients with no recurrence. CONCLUSIONS: Multidisciplinary treatment strategies should be used to accomplish durable locoregional control after BCT...
A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibilityLisa A Newman
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA
Ann Surg Oncol 9:228-34. 2002..Improved breast imaging methods after chemotherapy are necessary to improve accuracy in predicting the feasibility of BCT, especially in patients presenting with diffuse calcifications or multicentricity...
Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websitesFunda Meric
Section of Breast Surgery, Department of Surgical Oncology, University of Texas, USA
BMJ 324:577-81. 2002..To determine the characteristics of popular breast cancer related websites and whether more popular sites are of higher quality...
Multidisciplinary management of breast cancer concurrent with pregnancyAngela J Keleher
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
J Am Coll Surg 194:54-64. 2002..Above all, the patient with breast cancer diagnosed during pregnancy is best served by early and continued involvement of a multidisciplinary cancer treatment team...
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiationThomas A Buchholz
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
J Clin Oncol 20:17-23. 2002..To define clinical and pathologic predictors of local-regional recurrence (LRR) for patients treated with neoadjuvant chemotherapy and mastectomy without radiation...
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancerHenry M Kuerer
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 9:601-5. 2003..Breast ductal fluid can be obtained from women by simple nipple aspiration and may be useful for analyzing the microenvironment of the breast...
Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple dischargeNeslihan Cabioglu
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Am Coll Surg 196:354-64. 2003..In patients with pathologic discharge with normal findings on physical examination and other imaging studies, ductography might be the only means of localizing and resecting breast lesions associated with nipple discharge...
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapyAmit K Garg
Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 59:138-45. 2004..For most patients with clinical T1 or T2 disease and one to three positive lymph nodes, the 5-year risk for LRR was low, and the routine inclusion of postmastectomy radiotherapy does not appear to be justified...
Current comprehensive assessment and management of women at increased risk for breast cancerAlan B Hollingsworth
Department of Surgery, Mercy Health Center, Mercy Women s Center, 4300 McAuley Blvd, Oklahoma City, OK 73120, USA
Am J Surg 187:349-62. 2004....
Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situTina W F Yen
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 100:942-9. 2004..The current findings have implications for current trials evaluating aromatase inhibitors and other chemopreventive agents for this disease...
Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstructionAnees Chagpar
Department of Surgical Oncology, Box 444, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Am J Surg 187:164-9. 2004..Collaboration with a plastic surgery team may be beneficial in the surgical management of these patients...
Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancerIsabelle Bedrosian
Departments of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Ann Surg Oncol 10:1025-30. 2003..No significant clinicopathologic criteria were found to impact sensitivity of ultrasonography; however, excisional biopsy for diagnosis may be a confounding variable in subsequent axillary ultrasonography...
Revision of breast cancer staging: the 6th edition of the TNM ClassificationS Eva Singletary
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
Semin Surg Oncol 21:53-9. 2003..Revisions of the previous staging system are related to the number of affected axillary lymph nodes and to the classification of level III axillary lymph nodes and lymph nodes outside of the axilla...
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging ManualS Eva Singletary
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, Houston, TX 77030 4009, USA
Surg Clin North Am 83:803-19. 2003..By increasing the number of prognostic markers that can give independent information about patient outcome, physicians will be better able to determine optimal treatment approaches for individual patients...
Chest wall recurrence after mastectomy does not always portend a dismal outcomeAnees Chagpar
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Ann Surg Oncol 10:628-34. 2003..0001). CONCLUSIONS: Patients with CWR are a heterogeneous population. Patients with initial node-negative disease who develop CWR after 24 months have an optimistic prognosis, especially if they are treated with radiation...
Candidates for minimally invasive therapy of breast cancer: redefining the standardsS Eva Singletary
Ann Surg Oncol 10:591-2. 2003
A role for curative surgery in the treatment of selected patients with metastatic breast cancerS Eva Singletary
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, Texas 77030 4095, USA
Oncologist 8:241-51. 2003..The addition of chest x-rays as part of routine follow-up should be considered as a cost-effective approach for early assessment of metastases to the lung or sternum that may be appropriate for surgical excision...
Nipple aspirate fluid cytology in breast carcinomaSavitri Krishnamurthy
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 99:97-104. 2003..Cytologic-histologic correlations of NAF were performed in only a few studies...
Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancerRosa F Hwang
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Ann Surg Oncol 10:248-54. 2003..A scoring system incorporating these factors may help determine which patients would benefit from additional axillary surgery...
Rating the risk factors for breast cancerS Eva Singletary
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, TX 77030 4095, USA
Ann Surg 237:474-82. 2003..To update and summarize evidence of risk factors for breast cancer...
Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 yearsAttiqa N Mirza
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Ann Surg 235:10-26. 2002..Because of technical difficulties and variations in the measurement of many of these factors, tumor size and tumor grade remain the only markers that currently have broad clinical usefulness for this patient group...
